Michel Orsinger, Board of Directors - Takeda Pharmaceuticals

Profile Section

Michel Orsinger

Michel Orsinger


External Director

Mar 2001 - Chief Executive Officer and President, OTC Division Worldwide, Consumer Health, Novartis AG

Apr 2007 - President and Chief Executive Officer, Synthes, Inc. (currently Johnson & Johnson)

Jun 2012 - Worldwide Chairman, Global Orthopedics Group, DePuy Synthes Companies, Johnson & Johnson

Jun 2012 - Member of Global Management Team, Johnson & Johnson

Jun 2016 - External Director of the Company

Jun 2019 - External Director of the Company who is an ASC Member

Jun 2022 - External Director of the Company (to present)